Brava C18-BDS is a reversed-phase HPLC column based on high-purity, fully porous silica and modified with octadecyl (C18) groups combined with base deactivation (Base Deactivated Silica) technology. This phase minimizes silanol interactions, providing sharper peak shapes, especially for basic compounds. Designed for robust performance in routine and regulated environments, Brava C18-BDS is ideal for pharmaceutical and general-purpose reversed-phase applications requiring high reproducibility and selectivity.
Brava C18-BDS offers enhanced peak shape and consistent retention – the ideal choice for reliable reversed-phase chromatography involving basic analytes.
Octadecyl (C18) bonded phase with base deactivation (USP L1)
Reduced silanol activity for improved peak symmetry
Stable performance for basic and polar compounds
Fully porous silica with high mechanical and chemical stability
Available in 3 µm, 5 µm, and 10 µm particle sizes
Basic pharmaceutical compounds and their impurities
Method validation and transfer in regulated labs
Food and chemical component analysis
Reversed-phase separations requiring high reproducibility
| Particle Sizes |
|
|---|---|
| Pore Size | 145 Å |
| Surface Area | 180 m²/g |
| Phase/Modification | C18 |
| Particle Type | |
| Separation Mode | |
| USP Code | |
| Endcapping | Yes |
| Carbonload | 12.5 % |
| Phase | Material Number |
|---|---|
| Brava C18-BDS, 3 µm | 5204011 |
| Brava C18-BDS, 5 µm | 5204012 |
| Brava C18-BDS, 10 µm | 5204013 |